1995
DOI: 10.1016/0960-894x(95)00225-i
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and pharmacological profile of two novel heterocyclic chromanols, CP-80,798 and CP-85,958, as potent LTD4 receptor antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1995
1995
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…CP-199.330, CP-199.331, and CP-85.958, featuring a syn -chromanol backbone, are under clinical trials as selective leukotriene D4 (LTD4) antagonists for treating asthma (Figure ). The typical transition-metal-free routes to chroman-4-ol/ones involve the NHC-catalyzed ‘Stetter’ reaction and radical-mediated cyclization of O -allyl salicylaldehydes . However, these methods often suffer from poor diastereoselectivity.…”
mentioning
confidence: 99%
“…CP-199.330, CP-199.331, and CP-85.958, featuring a syn -chromanol backbone, are under clinical trials as selective leukotriene D4 (LTD4) antagonists for treating asthma (Figure ). The typical transition-metal-free routes to chroman-4-ol/ones involve the NHC-catalyzed ‘Stetter’ reaction and radical-mediated cyclization of O -allyl salicylaldehydes . However, these methods often suffer from poor diastereoselectivity.…”
mentioning
confidence: 99%